Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
0.67
Jul. 06, 2026 11:28:05- Change -0.0124 (-1.8238%)
- Volume 0
- Today's Open 0.6845
- Previous Close 0.6799
- Today's High 0.6845
- Today's Low 0.6513
- 52 Week High 1.595
- 52 Week Low 0.281